NTR

Nutrien Ltd.

Industrial/Transportation


Presented:03/01/2018
Price:49.49
Cap:$31.80B
Current Price:$47.90
Cap:$31.80B

Presented

Date03/01/2018
Price49.49
Market Cap$31.80B
Ent Value$45.91B
P/E Ratio128.19x
Book ValueN/A
Div Yield3.23%
Shares O/S840.16M
Ave Daily Vol2,079,510
Short IntN/A

Current

Price$47.90
Market Cap$31.80B
Nutrien Ltd. produces and distributes potash, nitrogen, and phosphate products for agricultural, industrial, and feed manufacturers worldwide. The company was founded on June 2, 2017 and is headquartered in Saskatoon, Canada.

Publicly traded companies mentioned herein: Arab Potash (APOT JR), Mosaic Co (MOS), Nutrien Ltd (NTR), Sociedad Quimica y Minera de Chile SA (SQM), Tesla Inc (TSLA)

Highlights

Nutrien (NTR) began trading on January 2, 2018, following the completion of the Potash/Agrium merger. The presenter is long at this time, seeing a favorable risk/ reward with the stock at ~$50 per share and the potential for a 50% to 100% gain over 12 - 24 months. Investors have “left most of the fertilizer companies for dead” following a five year period of dramatic underperformance relative to the market due to weak commodity prices (NTR is “incredibly sensitive” to phosphate, nitrogen, and potash prices). However, the company is deploying capital in the form of a healthy dividend and buyback program, must sell its substantial holdings of SQM and APC, and stands to benefit from $500MM+ in estimated cost synergies, as well as tight supply/ demand dynamics. If his thesis is correct, and NTR is at the bottom of the cycle with macro tailwinds, its EBITDA and FCF could potentially rise to $6.5B - $7B and $7.50 per share, respectively, over the next two years. This would be up from an expected $3.5B - $4B and $3 per share for 2018, and assumes a return to the average nutrient prices seen over the last eight years.

  • Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

  • Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Request access to DeMatteo Research for full access

Request Access

Already have an account?

Idea Discussion

Commentor 1 - 2 weeks ago

Signing up and creating account with us, unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Commentor 1 - 2 weeks ago

Signing up and creating account with us, unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Idea Discussions display submitted commentary from our investor community.

To read and participate in the discussion with the presenter and investor base, request access to DeMatteo

Request Access

Already have an account?

An error occurred loading this content. Try again later or contact us.